Lumida
/KRMD
⌘K
KORU Medical Systems Inc

KORU Medical Systems Inc

KRMD
$3.16USD↑+0.32%+0.01 today

MARKET CAP

145.9M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$3 – $3

52W RANGE

$3
$7

AI Summary

Stalk
TrimMedium

The stock remains in a Stage 4 decline with lower highs and lower lows, and medium-term directional asymmetry favors the downside. A recent momentum breakout has been met with resistance at declining EMAs and the 50DMA, suggesting exhaustion rather than reversal. Execution favors trimming positions into the current rally into the overhead resistance zone around the falling EMAs and 50DMA.

  • ↑Q1 2026 revenue reached $11.8M, up 22% YoY
  • ↑International revenues grew 35% YoY via European syringe conversions
  • ↓Negative earnings yield and book-to-price ratio signal valuation risk
Full analysis →

Buying

4

institutions

Selling

1

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY2.63 M11.04 M+256.53 K+7.7%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUY164.90 K692.58 K+119.00 K+249.3%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL28.52 K119.78 K+-41.91 K-60.6%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY19.76 K86.36 K+1.65 K+12.2%0.00%
MM

Millennium Management LLC

Q2 2026

BUYNEW16.36 K68.69 K+16.36 K+0.0%0.00%